Product Information

CONJUGATED ESTROGENS 0.45 MG TB is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $5.3140 per EA under NDC 50742038801. Its NADAC has been published 40 times since Feb 18, 2026.

FDA first approved this application on Oct 15, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CONJUGATED ESTROGENS 0.45 MG TB

estrogens, conjugated
$5.3140per EA

Strength

.45 mg/1

NDC

50742038801

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

ESTROGENS, CONJUGATED

Approval Type

Generic (ANDA)

FDA Application

ANDA214025

FDA Approved

10/15/2025

TE Code

AB

On Market Since

10/16/2025

Pharmacological Classes

Estrogen Receptor Agonists
Estrogen
Estrogens
Conjugated (USP)

Price Statistics

The NADAC for CONJUGATED ESTROGENS 0.45 MG TB has been published 40 times since Feb 18, 2026, and over the history we have for it it has declined 11.0%. The table below summarizes its recorded NADAC range and movement.

Current price$5.3140 per EA
All-time high$5.9705 (Mar 11, 2026)
All-time low$5.3140 (Nov 18, 2026)
52-week high$5.9705
52-week low$5.3140
Median price$5.8476
Average price$5.7583
Largest weekly change-2.9% (Sep 23, 2026)
Weeks tracked40
Tracking sinceFeb 18, 2026

Price History

1W

-0.6%

1M

-3.0%

3M

-5.8%

6M

-10.0%

1Y

N/A

3Y

N/A

5Y

N/A

All

-11.0%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CONJUGATED ESTROGENS 0.45 MG TB?

The current National Average Drug Acquisition Cost (NADAC) for CONJUGATED ESTROGENS 0.45 MG TB, manufactured by Ingenus Pharmaceuticals LLC, is $5.3140 per EA (NDC 50742038801), effective Nov 18, 2026.

How has the price of CONJUGATED ESTROGENS 0.45 MG TB changed over time?

Over the history we have for it, the NADAC for CONJUGATED ESTROGENS 0.45 MG TB has declined 11.0%. It has been tracked across 40 weekly CMS publications since Feb 18, 2026.

What are the highest and lowest recorded NADAC prices for CONJUGATED ESTROGENS 0.45 MG TB?

Since Feb 18, 2026, the NADAC for CONJUGATED ESTROGENS 0.45 MG TB has ranged from a low of $5.3140 (Nov 18, 2026) to a high of $5.9705 (Mar 11, 2026), with a median of $5.8476 per EA.

Are there cheaper alternatives to CONJUGATED ESTROGENS 0.45 MG TB?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CONJUGATED ESTROGENS 0.45 MG TB in a comparable dosage form, but none are currently priced below it.

Who manufactures CONJUGATED ESTROGENS 0.45 MG TB?

CONJUGATED ESTROGENS 0.45 MG TB (NDC 50742038801) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.